Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Bullock

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Current Medical Research and Opinion|August 9, 2005
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year periodRoger Bullock, Jacques Touchon, Howard Bergman, et al.
Drugs & Aging|July 24, 2003
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's diseaseGordon Wilcock, Ian Howe, Hilary Coles, et al.
Pharmacogenetics and Genomics|October 19, 2006
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's diseaseRafael Blesa, Roger Bullock, Yunsheng He, et al.
International Psychogeriatrics|January 13, 2006
Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informantsLori Frank, Andrew Lloyd, Jennifer A Flynn, et al.
International Journal of Alzheimer'S Disease|August 28, 2010
Trial designs likely to meet valid long-term Alzheimer's disease progression effects: learning from the past, preparing for the futureAaron S Kemp, George T Grossberg, Steven J Romano, et al.
Psychiatry and Clinical Neurosciences|February 12, 2025
REIMAGINE: A central nervous system basket trial showing safety and efficacy of vafidemstat on aggression in different psychiatric disordersMarc Ferrer, Vanesa Richarte, Laura Gisbert, et al.
Lancet (London, England)|July 22, 2008
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trialClive Holmes, Delphine Boche, David Wilkinson, et al.
Lancet (London, England)|January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trialMarisa Hanney, Vee Prasher, Nicola Williams, et al.
CNS Neuroscience & Therapeutics|April 8, 2010
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer diseaseMurat Emre, Roberto Bernabei, Rafael Blesa, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 29, 2005
Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortiumPhilippe H Robert, Frans R J Verhey, E Jane Byrne, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Current Medical Research and Opinion|August 9, 2005
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year periodRoger Bullock, Jacques Touchon, Howard Bergman, et al.
Drugs & Aging|July 24, 2003
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's diseaseGordon Wilcock, Ian Howe, Hilary Coles, et al.
Pharmacogenetics and Genomics|October 19, 2006
Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's diseaseRafael Blesa, Roger Bullock, Yunsheng He, et al.
International Psychogeriatrics|January 13, 2006
Impact of cognitive impairment on mild dementia patients and mild cognitive impairment patients and their informantsLori Frank, Andrew Lloyd, Jennifer A Flynn, et al.
International Journal of Alzheimer'S Disease|August 28, 2010
Trial designs likely to meet valid long-term Alzheimer's disease progression effects: learning from the past, preparing for the futureAaron S Kemp, George T Grossberg, Steven J Romano, et al.
Psychiatry and Clinical Neurosciences|February 12, 2025
REIMAGINE: A central nervous system basket trial showing safety and efficacy of vafidemstat on aggression in different psychiatric disordersMarc Ferrer, Vanesa Richarte, Laura Gisbert, et al.
Lancet (London, England)|July 22, 2008
Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trialClive Holmes, Delphine Boche, David Wilkinson, et al.
Lancet (London, England)|January 13, 2012
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trialMarisa Hanney, Vee Prasher, Nicola Williams, et al.
CNS Neuroscience & Therapeutics|April 8, 2010
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer diseaseMurat Emre, Roberto Bernabei, Rafael Blesa, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|November 29, 2005
Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortiumPhilippe H Robert, Frans R J Verhey, E Jane Byrne, et al.
Pageof 7